Detecting and Modulating the NF-kB Activity in Human Immune Cells: Generation of Human Cell Lines with Altered Levels of NF-B
NF-κB plays a pivotal role in immunity and inflammation and is considered to be a promising candidate for drug development. However, global suppression of NF-κB may have undesirable side-effects. Our data and the results of others suggest that each of the five NF-κB subunits may have a specific function in controlling the expression of inflammatory mediators in immune cells. Identifying the role for each NF-κB subunit in primary human immune cells will allow a more targeted approach to inhibiting NF-κB subunit-specific cellular functions. However, results obtained with primary human cells can often be inconsistent due to donor heterogeneity. Therefore one possible approach could be to generate human immune cell lines with stably inhibited expression of specific NF-κB subunit(s) as described in this chapter.
- Detection of Chromosome 13 Deletions by Fluorescent In Situ Hybridization
- Overexpression of PRV-1 Gene in Polycythemia Rubra Vera and Essential Thrombocythemia
- Genetic Analysis of Drug Resistance by Fluorescence In Situ Hybridization
- Inhibiting Proinflammatory NF-B Signaling Using Cell-Penetrating NEMO Binding Domain Peptides
- FACS-Based Detection of Phosphorylated Histone H3 for the Quantitation of Mitotic Cells
- Alterations in Oncogenes, Tumor Suppressor Genes, and Growth Factors Associated with Epithelial Ovarian Cancers
- Lectin Array-Based Strategies for Identifying Metastasis-Associated Changes in Glycosylation
- Immunohistochemical Detection of Ornithine Decarboxylase as a Measure of Chemosensitivity Testing
- Cationic Liposome Gene Transfer
- Clonogenic Cell Survival Assay